Delivery Order SPE2DB22D2206-SPE2DB25FJB22
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $3,846.96 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,153,581 units of AMBISOME 50 MG VIALS by December 21, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a long history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order was not set aside and is part of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The delivery order has a potential value of $1,923.48 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the Department of Defense, providing pharmaceutical products and medical supplies to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AmBisome 50 mg vials. The contract has a ceiling value of $4,523.90 and a completion date of May 20, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and a critical supplier of medical and pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AmBisome 50 mg vials. The contract has a firm fixed price of $34,749.46 and a period of performance ending on May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The $1,923.48 award is for pharmaceutical products to support military treatment programs and facilities, with a completion date of December 28, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, has a long history of providing pharmaceuticals, medical supplies, and related...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,167.20 firm fixed price contract is for the supply of AMBISOME 50 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal...
- Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4563772319 - AMBISOME 50 MG VIALS. The contract has a completion date of February 27, 2024 and a potential value of $2,517.84. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,035.68 order is for the delivery of AMBISOME 50 MG VIALS, a pharmaceutical product, with an ultimate completion date of April 2, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA). The $1,923.48 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJB22Delivery Order
The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used for serious systemic fungal infections. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill diverse medical procurement requirements, from specialty medications to generic drugs and medical devices across multiple therapeutic domains. This delivery order represents a routine pharmaceutical supply transaction within the company's broader role as a prime vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 7/24/25 |